News
Redefining drug discovery: Morocco’s biotech strategy for infectious and chronic diseases
11+ hour, 22+ min ago (348+ words) Africa's healthcare systems continue to face significant economic and epidemiological pressures. A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and cardiovascular conditions." For example, in 2024 malaria accounted for an estimated…...
Reframing obesity beyond stigma and simplicity
13+ hour, 22+ min ago (678+ words) Bringing together clinicians, researchers, patient advocates, and industry voices, the event marked the beginning of a broader effort to rethink how obesity is discussed " and, crucially, how people living with it are treated. The scale of the issue at hand…...
Threat of Trump's pharma tariffs looms again
12+ hour, 42+ min ago (426+ words) The US federal government is said to be preparing to announce tariffs of up to 100% on some pharmaceutical imports, focusing on companies that have not signed pricing deals with the Trump administration. A Bloomberg report, citing people familiar with the…...
AZ claims another win for Imfinzi in frontline liver cancer
11+ hour, 41+ min ago (567+ words) AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme. The new results come from the EMERALD-3 study, testing a combination of PD-L1 inhibitor Imfinzi (durvalumab) with AZ's CTLA4 inhibitor…...
Webinar wrap-up: How pharma can leverage AI-driven synthetic personas
14+ hour, 19+ min ago (922+ words) In a recent webinar sponsored by Lumanity " Using AI-driven synthetic personas to take your insights further " Damian Eade, Technology Transformation Officer, Insight, at Lumanity and St'phane Lebrat, Global Insights and Analytics Director at Takeda, discussed how, as AI continues to…...
Alzheimer's biotech Korsana to go public via reverse merger
14+ hour, 12+ min ago (508+ words) Korsana Biosciences only emerged onto the scene a few weeks ago, but is already planning to go public to raise funds for its Alzheimer's disease candidate. The start-up will achieve that through a reverse merger with Cyclerion Therapeutics, a Nasdaq-listed…...
DNA testing can help right racial imbalance in breast cancer
1+ day, 7+ hour ago (497+ words) Routine genomic testing could correct well-established disparities in breast cancer survival rates between white and black women, according to a new study. Black women have a 5% lower incidence of breast cancer compared to white women in the US, but have…...
WOMA 2025: Steering the Future of Pharma Strategy
1+ day, 10+ hour ago (217+ words) The global pharmaceutical industry is navigating more than just technological disruption; it is facing a fundamental redefinition of its socio-economic role. In a market shaped by intensifying regulatory pressures and the imperative for hyper-personalised medicine, value no longer resides solely…...
Human behaviour in cancer screening trials: A variable that goes unmeasured
1+ day, 10+ hour ago (385+ words) Cancer screening guidelines " which tests to use, when to begin screening, how often to screen " are built on the evidence generated by clinical trials. That evidence is typically presented as a question: "Does earlier detection improve outcomes?" The clinical research…...
Google News
1+ day, 10+ hour ago (9+ words) EMA seeks input on virtual alternative to animal test'pharmaphorum...